首页 > 市场调查报告书 > 医疗设备

体外诊断

血液凝固检验市场规模、份额和成长分析（按产品、检测方法、技术、应用、最终用户和地区划分）—产业预测，2026-2033年

市场调查报告书

商品编码

1898325

血液凝固检验市场规模、份额和成长分析（按产品、检测方法、技术、应用、最终用户和地区划分）—产业预测，2026-2033年

Coagulation Testing Market Size, Share, and Growth Analysis, By Product (Instruments, Consumables), By Test (Complete Blood Count (CBC), Factor V Assay), By Technology, By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，血液凝固检验市场规模将达到 42.6 亿美元，到 2025 年将达到 47.8 亿美元，到 2033 年将达到 120.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 12.2%。

受多种因素驱动，全球血液凝固检验市场正经历显着成长。血液凝固检验对于诊断和监测各种血液凝固相关疾病至关重要，而这些疾病与心血管疾病、血友病和血管性血友病等血液疾病的日益普遍密切相关。此外，需要精准诊断的外科手术和创伤病例数量的增加也进一步推动了对血液凝固检验的需求。同时，诊断产品和设备的严格监管要求在塑造市场格局方面发挥关键作用，迫使新参与企业必须达到品质标准并获得监管部门的核准。所有这些因素共同凸显了血液凝固检验在现代医学中的关键地位。

血液凝固检验市场驱动因素

心血管疾病发生率的上升和全球人口老化凸显了血液凝固检验作为关键诊断手段日益增长的需求。此外，光学和电化学血液凝固检验检测等诊断技术的创新，提高了检测结果的准确性和效率，从而促进了这些检测方法在各种医疗机构中的应用和普及。这些因素不仅凸显了血液凝固检验在患者管理中的重要性，也推动了其持续发展以满足日益增长的医疗需求。因此，这些发展共同推动了血液凝固检验市场的扩张。

血液凝固检验市场的限制因素

血液凝固检验市场面临的主要阻碍因素是检测方法标准化的挑战，尤其是不同检查室和环境下检测结果的差异。这些不一致给医疗专业人员准确解读检测结果带来了困难，影响了血液凝固检验的整体可靠性。因此，结果的不一致会阻碍有效的诊断和治疗，妨碍患者照护，并影响医疗专业人员和患者对检测过程的信心。解决这些标准化难题对于提高血液凝固检验实践的一致性和可靠性至关重要。

血液凝固检验市场趋势

血液凝固检验市场正经历着向就地检验（POC检测）的显着转变，这主要得益于对快速、分散式诊断解决方案日益增长的需求。这种转变的主要驱动力是急诊和门诊环境中对快速决策的需求，因为及时获得检测结果对患者预后至关重要。技术进步使得高度便携、易于操作的血液凝固检验设备得以开发，并正被越来越多地应用于各种医疗机构。随着医疗服务提供者将效率和以患者为中心的护理放在首位，这些创新检测解决方案的应用预计将持续成长，并重塑凝血诊断领域。

Roche Diagnostics（Switzerland）
Siemens Healthineers（Germany）
Abbott Laboratories（USA）
Instrumentation Laboratory（Werfen）（Spain）
Sysmex Corporation（Japan）
Thermo Fisher Scientific Inc.（USA）
bioMerieux SA（France）
Diagnostica Stago SAS（France）
Horiba, Ltd.（Japan）
Alere Inc.（USA）（now Abbott）
Haemonetics Corporation（USA）
Helena Laboratories Corporation（USA）
Medtronic plc（Ireland）
Agilent Technologies, Inc.（USA）
Sekisui Diagnostics（Japan）
Trinity Biotech plc（Ireland）
Kyowa Medex Co., Ltd.（Japan）
Maccura Biotechnology Co., Ltd.（China）

结论与建议

简介目录

Product Code: SQMIG35G2268

Coagulation Testing Market size was valued at USD 4.26 Billion in 2024 and is poised to grow from USD 4.78 Billion in 2025 to USD 12.01 Billion by 2033, growing at a CAGR of 12.2% during the forecast period (2026-2033).

The global Coagulation Testing Market is experiencing substantial growth, driven by several influencing factors. Coagulation testing is essential for diagnosing and monitoring various medical conditions related to blood clotting, aligning with the increasing prevalence of cardiovascular diseases and blood disorders, including hemophilia and von Willebrand disease. The demand for coagulation testing is further fueled by the rising number of surgical procedures and trauma cases that require precise diagnostics. Additionally, stringent regulatory requirements for diagnostic products and devices play a crucial role in shaping the market landscape, necessitating compliance with quality standards and regulatory approvals for new market entrants. This combination of factors highlights the critical importance of coagulation testing in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Coagulation Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Coagulation Testing Market Segments Analysis

Global Coagulation Testing Market is segmented by Product, Test, Technology, Application, End-User and region. Based on Product, the market is segmented into Instruments, Consumables, Reagents And Standards, Controls and Calibrations. Based on Test, the market is segmented into Complete Blood Count (CBC), Factor V Assay, Fibrinogen Level, Prothrombin Time, Platelet Count, Thrombin Time, Bleeding Time and Others. Based on Technology, the market is segmented into Optical Technology, Mechanical Technology, Electrochemical Technology and Others. Based on Application, the market is segmented into Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT) and Other. Based on End-User, the market is segmented into Hospitals, Clinical Laboratories, Point-of-Care Testing and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Coagulation Testing Market

The rising incidence of cardiovascular diseases, along with a worldwide aging population, highlights the escalating demand for coagulation testing as a crucial diagnostic resource. Moreover, innovations in diagnostic technology, such as optical and electrochemical coagulation testing methods, contribute to improved precision and efficiency of results. This leads to greater acceptance and implementation of these tests in various healthcare environments. The convergence of these factors not only emphasizes the importance of coagulation testing in patient management but also propels its continuous evolution to meet the growing healthcare needs. Consequently, these developments collectively drive the expansion of the coagulation testing market.

Restraints in the Coagulation Testing Market

A significant restraint within the coagulation testing market lies in the challenges related to the standardization of testing methodologies, particularly due to variations in results among different laboratories and environments. These discrepancies can create difficulties for healthcare professionals in accurately interpreting test outcomes, thereby impacting the overall reliability of coagulation testing. As a result, the inconsistency of results can hinder effective diagnosis and treatment, posing a hurdle in delivering optimal patient care and affecting the confidence of both practitioners and patients in the testing process. Addressing these standardization issues is crucial to enhance the coherence and trustworthiness of coagulation testing practices.

Market Trends of the Coagulation Testing Market

The coagulation testing market is experiencing a notable trend towards point-of-care testing, driven by the increasing demand for rapid and decentralized diagnostic solutions. This shift is primarily motivated by the necessity for swift decision-making in emergency and outpatient scenarios, where timely results can significantly impact patient outcomes. Advances in technology are enabling the development of portable, user-friendly coagulation testing devices, which are being embraced across diverse healthcare settings. As healthcare providers prioritize efficiency and patient-centric care, the adoption of these innovative testing solutions is expected to grow, reshaping the landscape of coagulation diagnostics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Coagulation Testing Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
Consumables
Reagents And Standards
Controls
Calibrations

Global Coagulation Testing Market Size by Test & CAGR (2026-2033)

Market Overview
Complete Blood Count (CBC)
Factor V Assay
Fibrinogen Level
Prothrombin Time
Platelet Count
Thrombin Time
Bleeding Time
Others

Global Coagulation Testing Market Size by Technology & CAGR (2026-2033)

Market Overview
Optical Technology
Mechanical Technology
Electrochemical Technology
Others

Global Coagulation Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Activated Clotting Time (ACT)
Thrombin Time (TT)
Partial Thromboplastin Time (PTT)
Activated Partial Thromboplastin Time (APTT)
Prothrombin Time (PT)
Other

Global Coagulation Testing Market Size by End-User & CAGR (2026-2033)

Market Overview
Hospitals
Clinical Laboratories
Point-of-Care Testing
Others

Global Coagulation Testing Market Size & CAGR (2026-2033)

North America (Product, Test, Technology, Application, End-User)
- US
- Canada
Europe (Product, Test, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Test, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Test, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Test, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Instrumentation Laboratory (Werfen) (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagnostica Stago SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (USA) (now Abbott)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haemonetics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Laboratories Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Diagnostics (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kyowa Medex Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maccura Biotechnology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments